Overview

Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether the administration of a low dose of tranexamic acid just after vaginal delivery can reduce the incidence of immediate postpartum hemorrhage, in women who receive a prophylactic administration of oxytocin.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Angers
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France
Treatments:
Oxytocin
Tranexamic Acid